0001209191-21-046030.txt : 20210708 0001209191-21-046030.hdr.sgml : 20210708 20210708181732 ACCESSION NUMBER: 0001209191-21-046030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210706 FILED AS OF DATE: 20210708 DATE AS OF CHANGE: 20210708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stalfort John A III CENTRAL INDEX KEY: 0001709418 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40551 FILM NUMBER: 211081208 MAIL ADDRESS: STREET 1: C/O ACUMEN PHARMACEUTICALS, INC. STREET 2: 427 PARK STREET CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 FORMER NAME: FORMER CONFORMED NAME: Stalfort Sean DATE OF NAME CHANGE: 20170615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acumen Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001576885 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 364108129 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4435 NORTH FIRST STREET, SUITE 360 CITY: LIVERMORE STATE: CA ZIP: 94551 BUSINESS PHONE: 925-368-8508 MAIL ADDRESS: STREET 1: 4435 NORTH FIRST STREET, SUITE 360 CITY: LIVERMORE STATE: CA ZIP: 94551 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-06 0 0001576885 Acumen Pharmaceuticals, Inc. ABOS 0001709418 Stalfort John A III C/O ACUMEN PHARMACEUTICALS, INC. 427 PARK STREET CHARLOTTESVILLE VA 22902 1 0 0 0 Common Stock 2021-07-06 4 C 0 130180 A 137324 D Common Stock 2021-07-06 4 P 0 35000 16.00 A 172324 D Common Stock 2021-07-06 4 C 0 131595 A 131595 I See footnote Series A-1 Preferred 2021-07-06 4 C 0 130180 0.00 D Common Stock 130180 0 D Series B Preferred 2021-07-06 4 C 0 131595 0.00 D Common Stock 131595 0 I See footnote On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and each share of Series B Convertible Preferred Stock converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. The securities are held by Gineane Holly Stalfort, as Trustee of the John A. Stalfort III 2018 Irrevocable Trust under agreement dated as of October 25, 2018. /s/ Katherine Denby, Attorney-in-Fact 2021-07-08